Mesenchymal stem cell derived-exosomes: a modern approach in translational medicine S Nikfarjam, J Rezaie, NM Zolbanin, R Jafari Journal of translational medicine 18, 1-21, 2020 | 283 | 2020 |
Acute respiratory distress syndrome in COVID-19: possible mechanisms and therapeutic management A Aslan, C Aslan, NM Zolbanin, R Jafari Pneumonia 13 (1), 14, 2021 | 97 | 2021 |
Fc-fusion proteins in therapy: an updated view R Jafari, N M Zolbanin, H Rafatpanah, J Majidi, T Kazemi Current medicinal chemistry 24 (12), 1228-1237, 2017 | 87 | 2017 |
The versatile role of exosomes in human retroviral infections: from immunopathogenesis to clinical application J Rezaie, C Aslan, M Ahmadi, NM Zolbanin, F Kashanchi, R Jafari Cell & Bioscience 11, 1-15, 2021 | 74 | 2021 |
Recent advances in mRNA-LNP therapeutics: immunological and pharmacological aspects SH Kiaie, N Majidi Zolbanin, A Ahmadi, R Bagherifar, H Valizadeh, ... Journal of nanobiotechnology 20 (1), 276, 2022 | 69 | 2022 |
Impacts of early intervention with fluoxetine following early neonatal immune activation on depression-like behaviors and body weight in mice MH Doosti, A Bakhtiari, P Zare, M Amani, N Majidi-Zolbanin, S Babri, ... Progress in Neuro-Psychopharmacology and Biological Psychiatry 43, 55-65, 2013 | 65 | 2013 |
Exosomes for mRNA delivery: a novel biotherapeutic strategy with hurdles and hope C Aslan, SH Kiaie, NM Zolbanin, P Lotfinejad, R Ramezani, F Kashanchi, ... BMC biotechnology 21, 1-12, 2021 | 64 | 2021 |
Neonatal NMDA receptor blockade alters anxiety-and depression-related behaviors in a sex-dependent manner in mice M Amani, H Samadi, MH Doosti, M Azarfarin, A Bakhtiari, ... Neuropharmacology 73, 87-97, 2013 | 64 | 2013 |
Anti-mucin1 aptamer-conjugated chitosan nanoparticles for targeted co-delivery of docetaxel and IGF-1R siRNA to SKBR3 metastatic breast cancer cells R Jafari, NM Zolbanin, J Majidi, F Atyabi, M Yousefi, F Jadidi-Niaragh, ... Iranian Biomedical Journal 23 (1), 21, 2019 | 55 | 2019 |
The PI3K/AKT signaling pathway in cancer: Molecular mechanisms and possible therapeutic interventions MR Khezri, R Jafari, K Yousefi, NM Zolbanin Experimental and molecular pathology 127, 104787, 2022 | 46 | 2022 |
Interleukin-1 in COVID-19 Infection: Immunopathogenesis and Possible Therapeutic Perspective A Mardi, S Meidaninikjeh, S Nikfarjam, N Majidi Zolbanin, R Jafari Viral immunology 34 (10), 679-688, 2021 | 40 | 2021 |
Azithromycin: Immunomodulatory and antiviral properties for SARS-CoV-2 infection MR Khezri, NM Zolbanin, M Ghasemnejad-Berenji, R Jafari European journal of pharmacology 905, 174191, 2021 | 39 | 2021 |
The role of regulatory T cells in the pathogenesis and treatment of prostate cancer V Karpisheh, SM Mousavi, PN Sheykholeslami, M Fathi, MM Saray, ... Life sciences 284, 119132, 2021 | 37 | 2021 |
Immunopharmacological perspective on zinc in SARS-CoV-2 infection SH Asl, S Nikfarjam, NM Zolbanin, R Nassiri, R Jafari International immunopharmacology 96, 107630, 2021 | 36 | 2021 |
Targeted co-delivery of docetaxel and cMET siRNA for treatment of mucin1 overexpressing breast cancer cells NM Zolbanin, R Jafari, J Majidi, F Atyabi, M Yousefi, F Jadidi-Niaragh, ... Advanced Pharmaceutical Bulletin 8 (3), 383, 2018 | 26 | 2018 |
Blockade of CD73 using siRNA loaded chitosan lactate nanoparticles functionalized with TAT-hyaluronate enhances doxorubicin mediated cytotoxicity in cancer cells both in vitro … AMS Khesht, V Karpisheh, PS Gilan, LA Melnikova, AO Zekiy, ... International journal of biological macromolecules 186, 849-863, 2021 | 22 | 2021 |
Selenium effect on oxidative stress factors in septic rats E Zolali, H Hamishehkar, N Maleki-Dizaji, NM Zolbanin, H Ghavimi, ... Advanced Pharmaceutical Bulletin 4 (3), 289, 2014 | 22 | 2014 |
Recent highlights in the immunomodulatory aspects of Treg cell-derived extracellular vesicles: special emphasis on autoimmune diseases and transplantation Y Asemani, S Najafi, F Ezzatifar, NM Zolbanin, R Jafari Cell & bioscience 12 (1), 67, 2022 | 20 | 2022 |
Testosterone replacement attenuates haloperidol-induced catalepsy in male rats NM Zolbanin, E Zolali, AM Nayebi Advanced Pharmaceutical Bulletin 4 (3), 237, 2014 | 14 | 2014 |
Selumetinib: a selective MEK1 inhibitor for solid tumor treatment M Hedayat, R Jafari, N Majidi Zolbanin Clinical and Experimental Medicine 23 (2), 229-244, 2023 | 11 | 2023 |